Can hyperthermic intraperitoneal chemotherapy effectively control gastric cancer-associated peritoneal carcinomatosis?  

作　　者：Chong-Chi Chiu Chao-Jung Tsao Jhi-Joung Wang Yutaka Yonemura 

机构地区：[1]Department of General Surgery,Chi Mei Medical Center,Liouying 73657 and Tainan 71004,Taiwan [2]Department of Electrical Engineering,Southern Taiwan University of Science and Technology,Tainan 71005,Taiwan [3]Department of Oncology,Chi Mei Medical Center,Liouying 73657,Taiwan [4]Department of Medical Research,Chi Mei Medical Center,Tainan 71004, Taiwan [5]AI Biomed Center,Southern Taiwan University of Science and Technology, Tainan 71005,Taiwan [6]Peritoneal Surface Malignancy Center,Kishiwada Tokushukai Hospital, Kishiwada,Osaka 596-8522,Japan

出　　处：《World Journal of Surgical Procedures》2019年第1期7-11,共5页世界外科手术杂志

基　　金：Supported by grant from Chi Mei Medical Center,Liouying,Taiwan,No.CLFHR10606

摘　　要：Gastric cancer-associated peritoneal carcinomatosis leads to a poor prognosis and low quality of life. The current systemic chemotherapy processes cannot effectively improve survival. Hyperthermic intraperitoneal chemotherapy (HIPEC) has been used as an alternative treatment to control this disease through recurrence prevention, definitive therapeutic modality, and symptom palliation. Although HIPEC has been demonstrated to yield favorable results mainly in some Asian studies, widespread adoption of this treatment is still debatable before larger prospective randomized controlled clinical trials confirm its effectiveness.Gastric cancer-associated peritoneal carcinomatosis leads to a poor prognosis and low quality of life.The current systemic chemotherapy processes cannot effectively improve survival.Hyperthermic intraperitoneal chemotherapy(HIPEC) has been used as an alternative treatment to control this disease through recurrence prevention,definitive therapeutic modality,and symptom palliation.Although HIPEC has been demonstrated to yield favorable results mainly in some Asian studies,widespread adoption of this treatment is still debatable before larger prospective randomized controlled clinical trials confirm its effectiveness.

关 键 词：Hyperthermic INTRAPERITONEAL CHEMOTHERAPY GASTRIC cancer PERITONEAL CARCINOMATOSIS 

分 类 号：R[医药卫生]